InvestorsHub on MSN
Tempus AI shares jump after company posts record $1.1BN contract backlog
Shares of Tempus AI, Inc. (NASDAQ:TEM) climbed around 12% on Monday after the precision medicine and data analytics company ...
Tempus AI stock contract value exceeds $1.1B with 70 pharma deals. Diagnostics revenue up 111%, data segment up 31% in 2025 ...
Combining microscopy and machine-learning techniques leads to faster, more precise analyses of critical coating materials ...
Abstract: To achieve high spatial resolution of X-ray imaging, the focal spot size of high-energy nondestructive testing electron accelerators has been progressively reduced from 2 to below 1 mm, and, ...
Abstract: High-resolution electron microscopy (HREM) imaging technique is a powerful tool for directly visualizing a broad range of materials in real-space. However, it faces challenges in denoising ...
Tempus AI is rated a strong buy for risk-tolerant investors, leveraging its vast proprietary healthcare data to drive precision medicine via AI and ML. TEM delivered 85% YoY revenue growth in Q3 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback